Morningside Venture Investments Ltd → Kezar Life Sciences, Inc. KZR

Stake: 8.45% Shares: 616,502 CUSIP: 49372L100 Class: Common Stock, par value $0.001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 10/100

Passive Schedule 13G filer baseline
High conviction ownership stake (8.4%)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest · settle 2026-04-30

DTC 2.28

158,519 shares short · +4.6% vs prior

Other 13D/G Filings on Kezar Life Sciences, Inc.

Filed	Form	Filer	Stake	Shares
2026-05-13	SCHEDULE 13D/A	TANG CAPITAL MANAGEMENT LLC	—	0	view →
2025-03-03	SCHEDULE	Equal Talent Investments Ltd	8.66%	616,502	view →
2021-02-16	SC	Morningside Venture Investments Ltd	—	—	view →
2020-06-16	SC	Morningside Venture Investments Ltd	—	—	view →

Other Filings by Morningside Venture Investments Ltd

Filed	Form	Issuer	Stake	Shares
2023-10-04	SC	Amylyx Pharmaceuticals, Inc. AMLX	—	—	view →
2023-04-03	SC	Amylyx Pharmaceuticals, Inc. AMLX	—	—	view →
2023-02-23	SC	LumiraDx Ltd	—	—	view →
2021-11-22	SC	Stealth BioTherapeutics Corp	—	—	view →
2021-02-16	SC	Kezar Life Sciences, Inc. KZR	—	—	view →
2020-06-16	SC	Kezar Life Sciences, Inc. KZR	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →